Document is current
Any future updates will be listed below
-
Authors
,
Tissot, Cécile
L. Benedet, Andréa
Therriault, Joseph
Pascoal, Tharick A.
Lussier, Firoza Z.
Saha-Chaudhuri, Paramita
Chamoun, Mira
Savard, Melissa
Mathotaarachchi, Sulantha S.
Bezgin, Gleb
Wang, Yi-Ting
Fernandez Arias, Jaime
Rodriguez, Juan Lantero
Snellman, Anniina
Ashton, Nicholas J.
Karikari, Thomas K.
Blennow, Kaj
Zetterberg, Henrik
De Villers-Sidani, Etienne
Huot, Philippe
Gauthier, Serge
Rosa-Neto, Pedro http://orcid.org/0000-0001-9116-1376
-
Funding
Funding for this research was provided by:
Canadian Institute of Health Research
Weston Brain Institute
Swedish Research Council
- License Information
-
More Information
Article History
Received: 23 October 2020
Accepted: 8 March 2021
First Online: 29 March 2021
Declarations
:
: Each ADNI site received approval from their Ethics Board to conduct the study. Written consent was obtained from all the research participants.
: Not applicable.
: CT, ALB, JT, TAP, FL, PSC, MC, MS, SM, GB, YTW, JFA, NJA, TKK, EDVS, PH, SG, and PR-N have no disclosures to report.HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, and CogRx; has given lectures in symposia sponsored by Fujirebio, Alzecure, and Biogen; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).
